Begin main content

Calls for Patient Input: Cerdelga and Glatiramer acetate

Published on: December 15, 2016
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

Cerdelga

Brand name Generic name Manufacturer Indication(s)
Cerdelga Eliglustat Genzyme Canada, a division of sanofi-aventis Canada Inc. Gaucher disease
Project Number Call for patient input Patient input deadline Submit patient input
TBC 2016-12-15 2017-02-10 Submit

Glatiramer acetate

Brand name Generic name Manufacturer Indication(s)
TBD Glatiramer acetate Pendopharm Multiple Sclerosis, relapsing - remitting
Project Number Call for patient input Patient input deadline Submit patient input
TBC 2016-12-15 2017-02-10 Submit